These results suggest that distinct E2F1 activity serves as a universal determinant, based on its fundamental mechanism of tumorigenesis, to distinguish between cancer cells and normal growing cells, and thereby provide means to specifically therapeutically target cancer cells, irrespective of tissue or cell types. This evidence concerns the gene E2F1 and cancer.